Association of polymorphisms in glutamate-cysteine ligase catalytic subunit and microsomal triglyceride transfer protein genes with nonalcoholic fatty liver disease

DNA and Cell Biology

Volumn 30, Issue 8, 2011, Pages 569-575

  Hashemi, Mohammad ^a   Hoseini, Hosnieh ^b   Yaghmaei, Parichehreh ^b   Moazeni Roodi, Abdolkarim ^c   Bahari, Ali ^d   Hashemzehi, Norallah ^e   Shafieipour, Sara ^e  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE CYSTEINE LIGASE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME ACTIVE SITE; FEMALE; GCLG GENE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MTTP GENE; NONALCOHOLIC FATTY LIVER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; CASE-CONTROL STUDIES; CATALYTIC DOMAIN; FATTY LIVER; FEMALE; GENOTYPE; GLUTAMATE-CYSTEINE LIGASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

TETRA;

EID: 79960968527     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2010.1162     Document Type: Article

References (36)

1. Berriot-Varoqueaux, N., Aggerbeck, L.P., Samson-Bouma, M., and Wetterau, J.R. (2000).The role of the microsomal triglyceride transfer protein in abetalipoproteinemia. Annu Rev Nutr 20, 663-697.
2. Blasiole, D.A., Davis, R.A., and Attie, A.D. (2007).The physiological and molecular regulation of lipoprotein assembly and secretion. Mol Biosyst 3, 608-619. (Pubitemid 47258227)
3. Browning, J.D., and Horton, J.D. (2004).Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 114, 147-152.\ (Pubitemid 39071617)
4. Brunt, E.M., Janney, C.G., Di Bisceglie, A.M., Neuschwander- Tetri, B.A., and Bacon, B.R. (1999).Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94, 2467-2474. (Pubitemid 29420675)
5. Chen, Y., Yang, Y., Miller, M.L., Shen, D., Shertzer, H.G., Stringer, K.F., Wang, B., Schneider, S.N., Nebert, D.W., and Dalton, T.P. (2007).Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure. Hepatology 45, 1118-1128. (Pubitemid 46775773)
6. Chen, Z., Newberry, E.P., Norris, J.Y., Xie, Y., Luo, J., Kennedy, S.M., and Davidson, N.O. (2008).ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice. J Lipid Res 49, 2013-2022.
7. Chitturi, S., and Farrell, G.C. (2001).Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 21, 27-41. (Pubitemid 32240484)
8. Cho, S., Hazama, M., Urata, Y., Goto, S., Horiuchi, S., Sumikawa, K., and Kondo, T. (1999).Protective role of glutathione synthesis in response to oxidized low density lipoprotein in human vascular endothelial cells. Free Radic Biol Med 26, 589-602. (Pubitemid 29146261)
9. Day, C.P., and James, O.F. (1998).Steatohepatitis: a tale of two "hits"? Gastroenterology 114, 842-845.
10. Diehl, A.M. (2002).Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines. Am J Physiol Gastrointest Liver Physiol 282, G1-G5.
11. Galloway, D.C., Blake, D.G., Shepherd, A.G., and McLellan, L.I. (1997).Regulation of human gamma-glutamylcysteine synthetase: co-ordinate induction of the catalytic and regulatory subunits in HepG2 cells. Biochem J 328 (Pt 1), 99-104. (Pubitemid 27499445)
12. George, J., Pera, N., Phung, N., Leclercq, I., Yun Hou, J., and Farrell, G. (2003).Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol 39, 756-764. (Pubitemid 37372185)
13. Hashemi, M., Bahari, A., Bahari, G., and Ghavami, S. (2008). Coenzyme Q10 may be effective in the treatment of non alcoholic fatty liver disease (NAFLD).Irn J Med Hypotheses Ideas 2, 1-4.
14. Hashemi, M., Moazeni-Roodi, A.K., Fazaeli, A., Sandoughi, M., Bardestani, G.R., Kordi-Tamandani, D.M., and Ghavami, S. (2010a).Lack of association between paraoxonase-1 Q192R polymorphism and rheumatoid arthritis in southeast Iran. Genet Mol Res 9, 333-339.
15. Hashemi, M., Moazeni-Roodi, A.K., Fazaeli, A., Sandoughi, M., Taheri, M., Bardestani, G.R., Zakeri, Z., Kordi-Tamandani, D.M., and Ghavami, S. (2010b).The L55M polymorphism of paraoxonase-1 is a risk factor for rheumatoid arthritis. Genet Mol Res 9, 1735-1741.
16. Hashimoto, E., Yatsuji, S., Tobari, M., Taniai, M., Torii, N., Tokushige, K., and Shiratori, K. (2009).Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. J Gastroenterol 44 Suppl 19, 89-95.
17. James, O.F., and Day, C.P. (1998).Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. J Hepatol 29, 495-501. (Pubitemid 28396672)
18. Jun, D.W., Han, J.H., Jang, E.C., Kim, S.H., Jo, Y.J., Park, Y.S., and Chae, J.D. (2009).Polymorphisms of microsomal triglyceride transfer protein gene and phosphatidylethanolamine Nmethyltransferase gene in alcoholic and nonalcoholic fatty liver disease in Koreans. Eur J Gastroenterol Hepatol 21, 667-672.
19. Koide, S., Kugiyama, K., Sugiyama, S., Nakamura, S., Fukushima, H., Honda, O., Yoshimura, M., and Ogawa, H. (2003). Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction. J Am Coll Cardiol 41, 539-545. (Pubitemid 36223316)
20. Leclercq, I.A., Farrell, G.C., Field, J., Bell, D.R., Gonzalez, F.J., and Robertson, G.R. (2000).CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 105, 1067-1075. (Pubitemid 30217691)
21. Ledmyr, H., Ottosson, L., Sunnerhagen, M., and Ehrenborg, E. (2006).The Ile128Thr polymorphism influences stability and ligand binding properties of the microsomal triglyceride transfer protein. J Lipid Res 47, 1378-1385. (Pubitemid 44079891)
22. Lu, S.C. (2009).Regulation of glutathione synthesis. Mol Aspects Med 30, 42-59.
23. Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M.,Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., and Rizzetto, M. (2003).Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37, 917-923. (Pubitemid 36397405)
24. Matteoni, C.A., Younossi, Z.M., Gramlich, T., Boparai, N., Liu, Y.C., and McCullough, A.J. (1999).Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116, 1413-1419. (Pubitemid 29258890)
25. Meister, A., and Anderson, M.E. (1983).Glutathione. Annu Rev Biochem 52, 711-760. (Pubitemid 13030692)
26. Mirandola, S., Realdon, S., Iqbal, J., Gerotto, M., Dal Pero, F., Bortoletto, G., Marcolongo, M., Vario, A., Datz, C., Hussain, M.M., and Alberti, A. (2006).Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. Gastroenterology 130, 1661-1669. (Pubitemid 43668848)
27. Mulcahy, R.T., Wartman, M.A., Bailey, H.H., and Gipp, J.J. (1997).Constitutive and beta-naphthoflavone-induced expression of the human gamma-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence. J Biol Chem 272, 7445-7454. (Pubitemid 27166457)
28. Namikawa, C., Shu-Ping, Z., Vyselaar, J.R., Nozaki, Y., Nemoto, Y., Ono, M., Akisawa, N., Saibara, T., Hiroi, M., Enzan, H., and Onishi, S. (2004).Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J Hepatol 40, 781-786. (Pubitemid 38507358)
29. Neville, M.J., Clarke, R., Grimley Evans, J., Rubinsztein, D.C., and Karpe, F. (2007).Absence of relationship between MTTP haplotypes and longevity. J Gerontol Med Sci 62A, 2020-2205.
30. Newton, C.R., Graham, A., Heptinstall, L.E., Powell, S.J., Summers, C., Kalsheker, N., Smith, J.C., and Markham, A.F. (1989). Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS).Nucleic Acids Res 17, 2503-2516. (Pubitemid 19103235)
31. Oliveira, C.P., Stefano, J.T., Cavaleiro, A.M., Zanella Fortes, M.A., Vieira, S.M., Rodrigues Lima, V.M., Santos, T.E., Santos, V.N., de Azevedo Salgado, A.L., Parise, E.R., Ferreira Alves, V.A., Carrilho, F.J., and Correa-Giannella, M.L. (2010). Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in nonalcoholic fatty liver disease. J Gastroenterol Hepatol 25, 357-361.
32. Rahman, I., and MacNee, W. (1999).Lung glutathione and oxidative stress: implications in cigarette smoke-induced airway disease. Am J Physiol 277, L1067-L1088. (Pubitemid 30046033)
33. Shindo, N., Fujisawa, T., Sugimoto, K., Nojima, K., Oze-Fukai, A., Yoshikawa, Y., Wang, X., Yasuda, O., Ikegami, H., and Rakugi, H. (2010).Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model. J Hepatol 52, 903-912.
34. Talmud, P.J., Palmen, J., Miller, G., and Humphries, S.E. (2000). Effect of microsomal triglyceride transfer protein gene variants (-493GT, Q95H and H297Q) on plasma lipid levels in healthy middle-aged UK men. Ann Hum Genet 64, 269-276.
35. Wetterau, J.R., Lin, M.C., and Jamil, H. (1997).Microsomal triglyceride transfer protein. Biochim Biophys Acta 1345, 136-150. (Pubitemid 27138415)
36. Ye, S., Dhillon, S., Ke, X., Collins, A.R., and Day, I.N. (2001).An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 29, E88-88.